Particle formation in spray drying R Vehring, WR Foss, D Lechuga-Ballesteros Journal of aerosol science 38 (7), 728-746, 2007 | 786 | 2007 |
Dry powder compositions having improved dispersivity M Kuo, D Lechuga-Ballesteros US Patent 6,518,239, 2003 | 277 | 2003 |
Trileucine improves aerosol performance and stability of spray‐dried powders for inhalation D Lechuga‐Ballesteros, C Charan, CLM Stults, CL Stevenson, DP Miller, ... Journal of pharmaceutical sciences 97 (1), 287-302, 2008 | 214 | 2008 |
Phase transition and heterogeneous/epitaxial nucleation of hydrated and anhydrous theophylline crystals N Rodríguez-Hornedo, D Lechuga-Ballesteros, HJ Wu International journal of pharmaceutics 85 (1-3), 149-162, 1992 | 149 | 1992 |
Heat-stable measles vaccine produced by spray drying S Ohtake, RA Martin, L Yee, D Chen, DD Kristensen, ... Vaccine 28 (5), 1275-1284, 2010 | 147 | 2010 |
Optimisation of powders for pulmonary delivery using supercritical fluid technology M Rehman, BY Shekunov, P York, D Lechuga-Ballesteros, DP Miller, ... European journal of pharmaceutical sciences 22 (1), 1-17, 2004 | 136 | 2004 |
Physical stability of salmon calcitonin spray-dried powders for inhalation HK Chan, AR Clark, JC Feeley, MC Kuo, SR Lehrman, K Pikal-Cleland, ... Journal of pharmaceutical sciences 93 (3), 792-804, 2004 | 135 | 2004 |
Improvement of the dispersibility of spray-dried budesonide powders using leucine in an ethanol–water cosolvent system MA Boraey, S Hoe, H Sharif, DP Miller, D Lechuga-Ballesteros, R Vehring Powder technology 236, 171-178, 2013 | 132 | 2013 |
Pharmaceutical liquid crystals: the relevance of partially ordered systems CL Stevenson, DB Bennett, D Lechuga-Ballesteros Journal of pharmaceutical sciences 94 (9), 1861-1880, 2005 | 123 | 2005 |
Cosuspensions of microcrystals and engineered microparticles for uniform and efficient delivery of respiratory therapeutics from pressurized metered dose inhalers R Vehring, D Lechuga-Ballesteros, V Joshi, B Noga, SK Dwivedi Langmuir 28 (42), 15015-15023, 2012 | 114 | 2012 |
Prediction of the onset of crystallization of amorphous sucrose below the calorimetric glass transition temperature from correlations with mobility C Bhugra, S Rambhatla, A Bakri, SP Duddu, DP Miller, MJ Pikal, ... Journal of pharmaceutical sciences 96 (5), 1258-1269, 2007 | 102 | 2007 |
Solid-state behavior of cromolyn sodium hydrates LR Chen, VG Young Jr, D Lechuga-Ballesteros, DJW Grant Journal of pharmaceutical sciences 88 (11), 1191-1200, 1999 | 94 | 1999 |
Room temperature stabilization of oral, live attenuated Salmonella enterica serovar Typhi-vectored vaccines S Ohtake, R Martin, A Saxena, B Pham, G Chiueh, M Osorio, D Kopecko, ... Vaccine 29 (15), 2761-2771, 2011 | 92 | 2011 |
Aerosolizable formulation comprising nicotine D Lechuga-Ballesteros, M Kuo, Y Song, B Bueche US Patent App. 11/169,153, 2006 | 92 | 2006 |
Single emulsion-solvent evaporation technique and modifications for the preparation of pharmaceutical polymeric nanoparticles M G Nava-Arzaluz, E Piñón-Segundo, A Ganem-Rondero, ... Recent patents on drug delivery & formulation 6 (3), 209-223, 2012 | 88 | 2012 |
The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state AM Abdul‐Fattah, D Lechuga‐Ballesteros, DS Kalonia, MJ Pikal Journal of pharmaceutical sciences 97 (1), 163-184, 2008 | 81 | 2008 |
Absorption of polyethylene glycol (PEG) polymers: the effect of PEG size on permeability H Gursahani, J Riggs-Sauthier, J Pfeiffer, D Lechuga-Ballesteros, ... Journal of pharmaceutical sciences 98 (8), 2847-2856, 2009 | 75 | 2009 |
Microcalorimetric measurement of the interactions between water vapor and amorphous pharmaceutical solids D Lechuga-Ballesteros, A Bakri, DP Miller Pharmaceutical research 20, 308-318, 2003 | 74 | 2003 |
Properties and stability of a liquid crystal form of cyclosporine—the first reported naturally occurring peptide that exists as a thermotropic liquid crystal D Lechuga-Ballesteros, A Abdul-Fattah, CL Stevenson, DB Bennett Journal of pharmaceutical sciences 92 (9), 1821-1831, 2003 | 72 | 2003 |
Drug delivery from an innovative LAMA/LABA co-suspension delivery technology fixed-dose combination MDI: evidence of consistency, robustness, and reliability A Doty, J Schroeder, K Vang, M Sommerville, M Taylor, B Flynn, ... AAPS PharmSciTech 19, 837-844, 2018 | 67 | 2018 |